AU Patent

AU2005282722C1 — Pyridyl inhibitors of hedgehog signalling

Assigned to Curis Royalty LLC · Expires 2011-08-18 · 15y expired

What this patent protects

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y, R, R, R, R, and n are as described herein.

USPTO Abstract

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y, R, R, R, R, and n are as described herein.

Drugs covered by this patent

Patent Metadata

Patent number
AU2005282722C1
Jurisdiction
AU
Classification
—
Expires
2011-08-18
Drug substance claim
No
Drug product claim
No
Assignee
Curis Royalty LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.